日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.

常染色体显性多囊肾病快速进展:尿液生物标志物作为预测指标

Messchendorp A Lianne, Meijer Esther, Visser Folkert W, Engels Gerwin E, Kappert Peter, Losekoot Monique, Peters Dorien J M, Gansevoort Ron T

T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease

采用T1加权和T2加权磁共振成像评估常染色体显性多囊肾病患者的肾脏总体积

van Gastel, Maatje D A; Messchendorp, A Lianne; Kappert, Peter; Kaatee, Merel A; de Jong, Marissa; Renken, Remco J; Ter Horst, Gert J; Mahesh, Shekar V K; Gansevoort, Ron T

Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients

在常染色体显性多囊肾病(ADPKD)患者中,由血管加压素V2受体拮抗引起的尿多与输尿管直径增大无关。

Casteleijn, Niek F; Messchendorp, A Lianne; Bae, Kyong T; Higashihara, Eiji; Kappert, Peter; Torres, Vicente; Meijer, Esther; Leliveld, Anna M

Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease

DIPAK 1 研究的原理和设计:一项随机对照临床试验,旨在评估兰瑞肽治疗常染色体显性多囊肾病阻止疾病进展的疗效。

Meijer, Esther; Drenth, Joost P H; d'Agnolo, Hedwig; Casteleijn, Niek F; de Fijter, Johan W; Gevers, Tom J; Kappert, Peter; Peters, Dorien J M; Salih, Mahdi; Soonawala, Darius; Spithoven, Edwin M; Torres, Vicente E; Visser, Folkert W; Wetzels, Jack F M; Zietse, Robert; Gansevoort, Ron T

Effects of microperfusion in hepatic diffusion weighted imaging

肝脏弥散加权成像中微灌注的影响

Dijkstra, Hildebrand; Baron, Paul; Kappert, Peter; Oudkerk, Matthijs; Sijens, Paul E